Please turn JavaScript on

Medpace Corporate

Subscribe to Medpace Corporate’s news feed.

Click on “Follow” and decide if you want to get news from Medpace Corporate via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to Medpace Corporate comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from Medpace Corporate which you are really interested in. Click on the blue “Filter” button below to get started.

Website title: Drug and Biologic Contract Research Organization (CRO) | Medpace

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.75 / week

Message History

Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs. This webinar will explore the current rare disease clinical development landscape and the key trends shaping its future.

The webinar will highl...


Read full story

Meet Dr. Sonia Quintas, MD, MSc, Medical Director

Medpace is proud to welcome Dr. Sonia Quintas, an accomplished and board-certified Neurologist, to our medical leadership team. Dr. Quintas brings nearly a decade of clinical and research experience across a broad spectrum of neurologic conditions, with deep specialized expertise in sleep disorders and headaches. ...


Read full story

Ensuring cardiovascular safety is an integral component of the drug development process. Early detection of potential cardiac risks—such as lengthening of the QT interval and other ECG abnormalities—with increasing drug exposure is essential to protecting the safety of trial participants. Additionally, a well-executed Concentration-QTc (C-QTc) analysis


Read full story

Meet Dr. Maxime Jeljeli, MD, PhD, Medical Director, Medpace

Medpace is pleased to announce the addition of a new immunology expert, Dr. Maxime Jeljeli, to the medical leadership team.

Dr. Jeljeli is a physician and scientist with over 13 years of combined clinical, academic, and pharmaceutical research experience in translational immunology....


Read full story

Behind many successful clinical trials is a central laboratory partner that understands both the science and operational challenges faced by Sponsors, sites, and patients. At Medpace’s central labs, our strength lies in experienced lead...


Read full story